Squeeze Report — September 25, 2026

Today's top short-squeeze candidates

1. #1GRPNGroupon, Inc. Common Stock81

   A #1 squeeze score (81.3) and activist demand for buybacks face cheap borrow and a convertible overhang that could supply shorts.

   SI 59%DTC 11.3$20.89+10% 20dCommunication Services
2. #2ORICOric Pharmaceuticals, Inc. Com81

   35% of float sold short · 16.2 days to cover · -5% over 20 days

   SI 35%DTC 16.2$13.18-5% 20dHealthcare
3. #3CNXCConcentrix Corporation Common80

   Q3 earnings land Sept 29 against 20.6% short interest and 7.5 days to cover, with an active buyback tightening the float.

   SI 21%DTC 7.5$29.39+5% 20dTechnology
4. #4NEONeoGenomics, Inc. Common Stock80

   67.6% short interest near a 52-week high is tempered by 0.25% borrow and convertible notes capping upside near $21.

   SI 68%DTC 9.0$19.56+13% 20dHealthcare
5. #5TNGXTango Therapeutics, Inc.79

   40% of float sold short · 19.7 days to cover · -3% over 20 days

   SI 40%DTC 19.7$24.63-3% 20dHealthcare
6. #6MMEDMiniMed Group, Inc. Common Sto78

   Short interest jumped 36.7% into a tight 27.5M-share float, but the exchange offer registering 225M new shares time-boxes any squeeze.

   SI 29%DTC 5.8$20.44+5% 20dHealthcare
7. #7SMMTSummit Therapeutics Inc. Commo77

   37.5% short with a Nov 14 PDUFA, but going-concern doubt and a $380M ATM give shorts real ammunition.

   SI 37%DTC 6.6$16.38+15% 20dHealthcare
8. #8ABSIAbsci Corporation Common Stock76

   25% of float sold short · 12.5 days to cover · +12% over 20 days

   SI 25%DTC 12.5$10.35+12% 20dHealthcare
9. #9VKTXViking Therapeutics, Inc. Comm76

   20% of float sold short · 12.4 days to cover · +7% over 20 days

   SI 20%DTC 12.4$36.75+7% 20dHealthcare
10. #10GLUEMonte Rosa Therapeutics, Inc.76

    16.6 days to cover and a trapped-short drawdown are undermined by no confirmed clinical catalyst and a $345M January offering.

    SI 30%DTC 16.6$11.72-18% 20dHealthcare
11. #11SEISolaris Energy Infrastructure,76

    A director's $501K buy and raised targets meet 33.9% short interest, though a $1.25B note deal and 18% share growth muddy the setup.

    SI 34%DTC 6.2$70.10+35% 20dEnergy
12. #12ARQTArcutis Biotherapeutics, Inc.76

    Short interest jumped 12.5% in two weeks, but options pricing 3% implied vol suggests no one is bracing for a squeeze.

    SI 15%DTC 9.4$26.27+4% 20dHealthcare
13. #13HALOHalozyme Therapeutics, Inc. Co75

    13% of float sold short · 8.7 days to cover · +8% over 20 days

    SI 13%DTC 8.7$115.22+8% 20dHealthcare
14. #14LQDALiquidia Corporation Common St74

    19% of float sold short · 10.2 days to cover · -1% over 20 days

    SI 19%DTC 10.2$70.95-1% 20dHealthcare
15. #15CRSPCRISPR Therapeutics AG Common74

    19.5% short with 10.7 days to cover, but flat price action and a $600M ATM keep the squeeze case inert.

    SI 20%DTC 10.7$55.70-6% 20dHealthcare